Atlantic Coastal (NASDAQ:ACAH) announced this morning that it and additive manufacturing firm Essentium have mutually agreed to terminate their business combination.
The press release did not provide much detail on the termination, but cited market conditions were unfavorable. Blake Teipel, CEO of Essentium, commented that they “are disappointed that market conditions prevented the parties from consummating this agreement” and will continue to “leverage the strength of additive manufacturing technology and product system validated by the Department of Defense to continue to advance additive manufacturing globally.”
The parties have agreed that Atlantic Coastal will be granted the right to receive payments subject to circumstances relating to the consummation of future financing transactions by Essentium, a sale of Essentium, or Atlantic Coastal’s inability to consummate a business combination. The parties have also agreed that if Essentium does not make a sale by March 8, 2023, then it will have to deliver a warrant to Atlantic Coastal to acquire a stake equal to five percent at an implied valuation equal to $500 million.
Atlantic Coastal planned on bringing about $345 million into the deal from its current trust supplemented by a $42 million PIPE. The PIPE drew participation from strategic and institutional investors including chemical conglomerate BASF (DE:BASF), Atalaya Capital Management and Apeiron Investment Group.
An affiliate of Atlantic Coastal’s sponsor initially funded its $20 million participation in the PIPE with a term loan from Cantor Fitzgerald secured by 8,425,000 Class A shares and 2,000,000 more as collateral. Atalaya Capital Management further supported the deal with a forward purchase agreement (FPA) which was supposed to see 10,000,000 shares, or enough to equal a 9.9% stake, if lesser, at close.
Going forward, Atlantic Coastal will focus its efforts on “identifying a next-generation mobility target with access to unique opportunities”. The SPAC still has plenty of time for a second try with its transaction deadline not coming until March 8, 2023.
Atlantic Coastal initially announced its $974 million combination with Essentium not too long ago on December 1. College Station, Texas-based Essentium provides machines that can remotely print tools and parts for the defense sector as well as a variety of civilian clients.
Aimei Health Technology II Co., Ltd (NASDAQ:AHJKU) has filed for a $60 million SPAC ostensibly to pair up with a small cap biotech or medical device target, but its team’s experience both in SPACs and beyond suggest the vehicle will be open to a broad set of potential targets. It is the first SPAC to...
At the SPAC of Dawn The markets got to open one stocking early yesterday, but it was mostly coal as it showed durable goods orders had declined by more than twice as much as expected to -1.1% in November. It wasn’t all signs of naughtiness, however. Amid the numbers that came public one day earlier...
Copley Acquisition Corp has filed to raise a $150 million SPAC to hunt for a technology or lifestyle target in either the Asia Pacific or North America regions. The new S-1 also advances underwriter Clear Street in the league tables as it has backed two of the three latest SPACs to file in December, and...
Translational Development Acquisition Corp. (NASDAQ: TDACU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TDACU”, Monday, December 23, 2024. The new SPAC intends to take a generalist approach in searching for a business combination, but intend to focus on industries that...
At the SPAC of Dawn SPACs have set to have a busy holiday week with three business combination approval votes and eight special meetings for extensions. Teams are trying to get eight of these in the books today, including all three completion votes ahead of Christmas Eve tomorrow. As noted last week, the theme of...